; (B) in subparagraph (C), by striking the period at the end and inserting ; and ; and (C) by adding at the end the following: (D) the development and procurement of priority medicines designated under section 2804. ; and (2) by adding at the end the following: (3) Priority medicines With respect to the development and procurement of priority medicines, the Secretary shall promote a diverse and sustainable supply chain, including through grants and purchases. . (e) Critical drug consideration Section 3101 of the CARES Act ( Public Law 116–136 ) is amended— (1) by redesignating subsection (d) as subsection (e); and (2) after executing the redesignation in paragraph (1), by inserting after subsection (c) the following: (d) Consideration With respect to any analysis of a critical drug under subsection (b)(1), the Secretary shall consider the vulnerability of such drug with respect to the global supply chain, including an analysis of— (1) the number of manufacturers of such drug; (2) the manufacturing locations, and amounts produced, of such drug; (3) the history of the importation of such drug